Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

EPA:ALGEV - Euronext Paris - Matif - FR0000033888 - Common Stock - Currency: EUR

188  +1 (+0.53%)

Fundamental Rating

3

Overall ALGEV gets a fundamental rating of 3 out of 10. We evaluated ALGEV against 106 industry peers in the Machinery industry. ALGEV has a great financial health rating, but its profitability evaluates not so good. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
In the past year ALGEV had a positive cash flow from operations.
ALGEV had positive earnings in each of the past 5 years.
ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALGEV's Return On Assets of 1.21% is on the low side compared to the rest of the industry. ALGEV is outperformed by 60.38% of its industry peers.
ALGEV has a Return On Equity of 1.52%. This is in the lower half of the industry: ALGEV underperforms 66.98% of its industry peers.
ALGEV has a Return On Invested Capital of 0.76%. This is in the lower half of the industry: ALGEV underperforms 79.25% of its industry peers.
ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.48%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ALGEV has a Profit Margin of 2.38%. This is comparable to the rest of the industry: ALGEV outperforms 46.23% of its industry peers.
ALGEV's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.68%, ALGEV is not doing good in the industry: 77.36% of the companies in the same industry are doing better.
ALGEV's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 63.62%, ALGEV belongs to the best of the industry, outperforming 90.57% of the companies in the same industry.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALGEV is destroying value.
The number of shares outstanding for ALGEV has been reduced compared to 1 year ago.
The number of shares outstanding for ALGEV has been reduced compared to 5 years ago.
Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.75 indicates that ALGEV is not in any danger for bankruptcy at the moment.
ALGEV has a Altman-Z score of 3.75. This is amongst the best in the industry. ALGEV outperforms 82.08% of its industry peers.
ALGEV has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, ALGEV belongs to the best of the industry, outperforming 87.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.75
ROIC/WACC0.1
WACC7.69%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 5.18 indicates that ALGEV has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.18, ALGEV belongs to the best of the industry, outperforming 94.34% of the companies in the same industry.
A Quick Ratio of 3.79 indicates that ALGEV has no problem at all paying its short term obligations.
ALGEV has a Quick ratio of 3.79. This is amongst the best in the industry. ALGEV outperforms 96.23% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -75.10% in the last year.
The earnings per share for ALGEV have been decreasing by -17.19% on average. This is quite bad
Looking at the last year, ALGEV shows a decrease in Revenue. The Revenue has decreased by -8.66% in the last year.
Measured over the past years, ALGEV shows a small growth in Revenue. The Revenue has been growing by 5.90% on average per year.
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 43.02, ALGEV can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ALGEV is valued a bit more expensive than the industry average as 61.32% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.30. ALGEV is valued rather expensively when compared to this.
ALGEV is valuated correctly with a Price/Forward Earnings ratio of 13.89.
ALGEV's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.76. ALGEV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 43.02
Fwd PE 13.89
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALGEV indicates a slightly more expensive valuation: ALGEV is more expensive than 67.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.97
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)12.13
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.70%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, ALGEV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, ALGEV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.7%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

117.62% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

GEVELOT SA

EPA:ALGEV (7/11/2025, 7:00:00 PM)

188

+1 (+0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)10-30 2025-10-30
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap141.00M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.7%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 43.02
Fwd PE 13.89
P/S 1.02
P/FCF N/A
P/OCF 32.64
P/B 0.65
P/tB 0.66
EV/EBITDA 13.97
EPS(TTM)4.37
EY2.32%
EPS(NY)13.53
Fwd EY7.2%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.06%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)12.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexcg growth 3Y-45.56%
ROICexcg growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.75
F-Score6
WACC7.69%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%